These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9631001)

  • 1. Suicidal tumor proteases.
    Sloane BF
    Nat Biotechnol; 1996 Jul; 14(7):826-7. PubMed ID: 9631001
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proteases and protease inhibitors in the treatment of cancer].
    Brünner NA
    Ugeskr Laeger; 1999 Mar; 161(11):1577-80. PubMed ID: 10202439
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting matrix metalloproteinases in human prostate cancer.
    Sang QA; Schwartz MA; Li H; Chung LW; Zhau HE
    Ann N Y Acad Sci; 1999 Jun; 878():538-40. PubMed ID: 10415766
    [No Abstract]   [Full Text] [Related]  

  • 4. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration.
    Okamoto I; Kawano Y; Tsuiki H; Sasaki J; Nakao M; Matsumoto M; Suga M; Ando M; Nakajima M; Saya H
    Oncogene; 1999 Feb; 18(7):1435-46. PubMed ID: 10050880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proteases in malignant tumors. Their significance for pathogenesis and possible therapeutic consequences].
    Fröhlich E
    Dtsch Med Wochenschr; 2004 Feb; 129(8):391-5. PubMed ID: 14961448
    [No Abstract]   [Full Text] [Related]  

  • 6. Membrane type-matrix metalloproteinases and tumor progression.
    Sounni NE; Noel A
    Biochimie; 2005; 87(3-4):329-42. PubMed ID: 15781320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
    Duivenvoorden WC; Hirte HW; Singh G
    Invasion Metastasis; 1997; 17(6):312-22. PubMed ID: 9949290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism-based inhibition of zinc proteases.
    Kim DH; Mobashery S
    Curr Med Chem; 2001 Jul; 8(8):959-65. PubMed ID: 11375763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.
    Groneberg RD; Burns CJ; Morrissette MM; Ullrich JW; Morris RL; Darnbrough S; Djuric SW; Condon SM; McGeehan GM; Labaudiniere R; Neuenschwander K; Scotese AC; Kline JA
    J Med Chem; 1999 Feb; 42(4):541-4. PubMed ID: 10052961
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthetic matrix metalloproteinase inhibitors and tissue inhibitor of metalloproteinase (TIMP)-2, but not TIMP-1, inhibit shedding of tumor necrosis factor-alpha receptors in a human colon adenocarcinoma (Colo 205) cell line.
    Lombard MA; Wallace TL; Kubicek MF; Petzold GL; Mitchell MA; Hendges SK; Wilks JW
    Cancer Res; 1998 Sep; 58(17):4001-7. PubMed ID: 9731514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent, achiral matrix metalloproteinase inhibitors.
    Pikul S; McDow Dunham KL; Almstead NG; De B; Natchus MG; Anastasio MV; McPhail SJ; Snider CE; Taiwo YO; Rydel T; Dunaway CM; Gu F; Mieling GE
    J Med Chem; 1998 Sep; 41(19):3568-71. PubMed ID: 9733482
    [No Abstract]   [Full Text] [Related]  

  • 12. Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer.
    Zervos EE; Shafii AE; Rosemurgy AS
    J Surg Res; 1999 Jan; 81(1):65-8. PubMed ID: 9889060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase inhibition suppresses MMP-2 activity and activation of PANC-1 cells in vitro.
    Zervos EE; Shafii AE; Haq M; Rosemurgy AS
    J Surg Res; 1999 Jun; 84(2):162-7. PubMed ID: 10357914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex roles of tissue inhibitors of metalloproteinases in cancer.
    Jiang Y; Goldberg ID; Shi YE
    Oncogene; 2002 Mar; 21(14):2245-52. PubMed ID: 11948407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From a unique cell to metastasis is a long way to go: clues to stromelysin-3 participation.
    Rio MC
    Biochimie; 2005; 87(3-4):299-306. PubMed ID: 15781316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular proteases as targets for treatment of cancer metastases.
    Lee M; Fridman R; Mobashery S
    Chem Soc Rev; 2004 Sep; 33(7):401-9. PubMed ID: 15354221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cellular proteases and invasion].
    Roessner A; Krüger S; Kido A
    Verh Dtsch Ges Pathol; 2000; 84():69-76. PubMed ID: 11217451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases of human NK cells.
    Albertsson P; Kim MH; Jonges LE; Kitson RP; Kuppen PJ; Johansson BR; Nannmark U; Goldfarb RH
    In Vivo; 2000; 14(1):269-76. PubMed ID: 10757086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition of matrix metalloproteases by tissue inhibitors of metalloproteases revealed by X-ray crystallography.
    Hewitt L; Lewis RJ; Dodson EJ
    Gen Physiol Biophys; 1998 Jun; 17 Suppl 1():46-9. PubMed ID: 9789754
    [No Abstract]   [Full Text] [Related]  

  • 20. Local proteolytic activity in tumor cell invasion and metastasis.
    Ludwig T
    Bioessays; 2005 Nov; 27(11):1181-91. PubMed ID: 16237672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.